www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-deSmartHouse Media GmbHhttp://finanzen.net/images/finanzen_net.gifhttp://www.finanzen.nethttp://www.finanzen.net/nachricht/Validity_of_Allergan_Patents_Acknowledged_by_Jan_Marini_in_Settlement_of_Allergan_s_Patent_Infringement_Suit_Against_Jan_Marini_Skin_Research_Inc__755392Allergan, Inc. (NYSE:AGN) announced today that it has agreed to dismiss its legal action against Jan Marini Skin Research, Inc. ("Jan Marini”), one of the defendants in Allergan’s patent infringement lawsuit pending in the United ...http://www.finanzen.net/nachricht/Validity_of_Allergan_Patents_Acknowledged_by_Jan_Marini_in_Settlement_of_Allergan_s_Patent_Infringement_Suit_Against_Jan_Marini_Skin_Research_Inc__755392http://www.finanzen.net/nachricht/Allergan_Receives_U_S_Food_and_Drug_Administration_Approval_for_TRIVARIS_TM__triamcinolone_acetonide_injectable_suspension_80_mg_mL_741836Allergan, Inc. (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved TRIVARIS™ (triamcinolone acetonide injectable suspension) 80 mg/mL, a synthetic glucocorticoid corticosteroid with anti-inflammatory ...http://www.finanzen.net/nachricht/Allergan_Receives_U_S_Food_and_Drug_Administration_Approval_for_TRIVARIS_TM__triamcinolone_acetonide_injectable_suspension_80_mg_mL_741836http://www.finanzen.net/nachricht/Allergan_Announces_Intent_to_File_New_Drug_Application_for_Bimatoprost_as_Novel_Treatment_to_Stimulate_Natural_Eyelash_Growth_736056Allergan, Inc. (NYSE:AGN) announced today that it intends to file a New Drug Application by end of the third quarter of 2008 with the U.S. Food and Drug Administration (FDA) for bimatoprost, a synthetic prostaglandin analog, as a ...http://www.finanzen.net/nachricht/Allergan_Announces_Intent_to_File_New_Drug_Application_for_Bimatoprost_as_Novel_Treatment_to_Stimulate_Natural_Eyelash_Growth_736056http://www.finanzen.net/nachricht/THE_Aesthetic_Show_Advances_34_Billion_Market_724978LAS VEGAS, May 14 /PRNewswire/ -- More than 2,000 physicians, researchers, Wall Street analysts and industry executives will gather at the Mandalay Bay Resort for THE Aesthetic Show, May 30 - June 1, 2008. With the most comprehensive and progressive ...http://www.finanzen.net/nachricht/THE_Aesthetic_Show_Advances_34_Billion_Market_724978http://www.finanzen.net/nachricht/Allergan_Reports_First_Quarter_2008_Operating_Results_721061Allergan, Inc. (NYSE: AGN) today announced operating results for the quarter ended March 31, 2008. Allergan also announced that its Board of Directors has declared a first quarter dividend of $0.05 per share, payable on June 13, 2008 ...http://www.finanzen.net/nachricht/Allergan_Reports_First_Quarter_2008_Operating_Results_721061http://www.finanzen.net/nachricht/Seven_Summits_Research_Releases_Comments_on_JAVA_WFC_CHK_LOW_and_AGN_718339CHICAGO, May 2 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks.Seven Summits Strategic Investments NewsBites are available to all investors at:http://www.go7now.com/nb/0502Y (Note: You may have to copy this link into your browser ...http://www.finanzen.net/nachricht/Seven_Summits_Research_Releases_Comments_on_JAVA_WFC_CHK_LOW_and_AGN_718339http://www.finanzen.net/nachricht/Allergan_Announces_Research__Development_Technology_Review_718000Allergan, Inc. (NYSE: AGN) will host a Research & Development Technology Review highlighting key projects on Wednesday, June 4, 2008 at 1 p.m. Eastern Time, 10 a.m. Pacific Time. The live Web cast can be accessed through the Allergan ...http://www.finanzen.net/nachricht/Allergan_Announces_Research__Development_Technology_Review_718000http://www.finanzen.net/nachricht/Allergan_Announces_Quarterly_Conference_Call_705387Allergan, Inc. (NYSE: AGN) invites you to listen to David Pyott, Chairman of the Board and Chief Executive Officer, and Jeff Edwards, Executive Vice President, Finance and Business Development, Chief Financial Officer, discuss the ...http://www.finanzen.net/nachricht/Allergan_Announces_Quarterly_Conference_Call_705387http://www.finanzen.net/nachricht/Seven_Summits_Research_Releases_Alerts_on_JPM_QCOM_AGN_UTX_and_ZMH_702094CHICAGO, April 2, 2008 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks.Seven Summits Strategic Investments' PriceWatch Alerts are available athttp://www.iotogo.com/s/040208A (Note: You may have to copy this link into your ...http://www.finanzen.net/nachricht/Seven_Summits_Research_Releases_Alerts_on_JPM_QCOM_AGN_UTX_and_ZMH_702094http://www.finanzen.net/nachricht/Allergan_Comments_on_the_United_States_Department_of_Justice_Subpoena_for_the_Production_of_Documents_Relating_to_Promotional_Practices_of_BOTOX_R_for_Therapeutic_Uses_686587Allergan, Inc. (NYSE: AGN) today announced that it received a subpoena from the United States Department of Justice, United States Attorney’s Office for the Northern District of Georgia requesting the production of documents regarding ...http://www.finanzen.net/nachricht/Allergan_Comments_on_the_United_States_Department_of_Justice_Subpoena_for_the_Production_of_Documents_Relating_to_Promotional_Practices_of_BOTOX_R_for_Therapeutic_Uses_686587